Florian Wiede

9PUBLICATIONS
68CO-AUTHORS
Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 10, 2026
A decline in skeletal muscle NOX4 abrogates exercise-induced adaptive homeostasis and exacerbates biological aging.

|Oct 29, 2025
Targeting PTPN2 enhances human CAR T cell efficacy and the development of long-term memory in mouse xenograft models.

Xin Du, Pei K Goh, Chenkai Ma

|Oct 25, 2022
Stepwise progression of β-selection during T cell development involves histone deacetylation.

Anchi S Chann, Mirren Charnley, Lucas M Newton

|Feb 23, 2022
PTPN2 elicits cell autonomous and non-cell autonomous effects on antitumor immunity in triple-negative breast cancer.

Pei Kee Goh, Florian Wiede, Mara N Zeissig

|Nov 19, 2021
PTP1B Is an Intracellular Checkpoint that Limits T-cell and CAR T-cell Antitumor Immunity.

Florian Wiede, Kun-Hui Lu, Xin Du

|Dec 21, 2019
A class of γδ T cell receptors recognize the underside of the antigen-presenting molecule MR1.

Jérôme Le Nours, Nicholas A Gherardin, Sri H Ramarathinam

Pageof 2

Frequent Collaborators

8 joint publications

Tony Tiganis

2 joint publications

Dale I Godfrey

2 joint publications

Shuwei Liang

2 joint publications

Pei Kee Goh